- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 491/107 - Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Patent holdings for IPC class C07D 491/107
Total number of patents in this class: 1877
10-year publication summary
|
149
|
162
|
128
|
135
|
177
|
187
|
194
|
207
|
204
|
50
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
57 |
| VALO Health, Inc. | 147 |
44 |
| Hoffmann-La Roche Inc. | 3060 |
41 |
| F. Hoffmann-La Roche AG | 7958 |
35 |
| Takeda Pharmaceutical Company Limited | 2961 |
34 |
| Merck Sharp & Dohme LLC | 3689 |
34 |
| Merck Patent GmbH | 5909 |
32 |
| Bristol-myers Squibb Company | 5080 |
30 |
| Kala bio, Inc. | 51 |
30 |
| Gilead Sciences, Inc. | 1879 |
26 |
| Amgen Inc. | 3779 |
20 |
| Boehringer Ingelheim International GmbH | 4629 |
19 |
| Bayer Pharma AG | 1096 |
19 |
| Vertex Pharmaceuticals Incorporated | 1581 |
19 |
| Bayer AG | 3045 |
18 |
| AstraZeneca AB | 3042 |
17 |
| Genentech, Inc. | 3742 |
16 |
| Janssen Pharmaceutica N.V. | 3839 |
15 |
| Epizyme, Inc. | 383 |
15 |
| Shionogi & Co., Ltd. | 914 |
15 |
| Other owners | 1341 |